FMR LLC 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-05 1:20 pm Purchase | 2025-12-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | FMR LLC | 24,688,109 14.600% | 4,168,142 (+20.31%) | Filing |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | FMR LLC | 20,519,967 12.400% | 5,123,767 (+33.28%) | Filing |
| 2025-11-05 11:30 am Purchase | 2025-09-30 | 13G | CYTOMX THERAPEUTICS INC CTMX | FMR LLC | 15,396,200 9.300% | 6,157,332 (+66.65%) | Filing |
| 2025-08-06 11:56 am Purchase | 2025-06-30 | 13G | CYTOMX THERAPEUTICS INC CTMX | FMR LLC | 9,238,868 5.900% | 7,100,090 (+331.97%) | Filing |